Logo 535 (Juvisync simvastatin 20 mg / sitagliptin 50 mg)
Generic Name: simvastatin/sitagliptin
Pill imprint Logo 535 has been identified as Juvisync simvastatin 20 mg / sitagliptin 50 mg.
Juvisync is used in the treatment of diabetes, type 2; high cholesterol, familial homozygous; high cholesterol, familial heterozygous; high cholesterol; cardiovascular risk reduction and belongs to the drug classes antidiabetic combinations, antihyperlipidemic combinations. Not for use in pregnancy. Juvisync simvastatin 20 mg / sitagliptin 50 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- Logo 535
- simvastatin 20 mg / sitagliptin 50 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Merck & Company Inc
More about Juvisync (simvastatin / sitagliptin)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: antidiabetic combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.